Evidence map›Paper›PMID 36366329›Full record

ArticleVaccines2022

Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5: Effect of Social Behavior.

Sachiko Kodera, Yuki Niimi, Essam A Rashed, Naoki Yoshinaga, Masashi Toyoda, Akimasa Hirata

Abstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sachiko KoderaDepartment of Electrical and Mechanical Engineering, Nagoya Institute of Technology, Nagoya 466-8555, Japan.ORCID 0000-0001-6595-0742
Yuki NiimiDepartment of Electrical and Mechanical Engineering, Nagoya Institute of Technology, Nagoya 466-8555, Japan.ORCID 0000-0002-4743-6018
Essam A RashedGraduate School of Information Science, University of Hyogo, Kobe 650-0047, Japan.ORCID 0000-0001-6571-9807
Naoki YoshinagaInstitute of Industrial Science, the University of Tokyo, Tokyo 153-8505, Japan.ORCID 0000-0002-2160-2604
Masashi ToyodaInstitute of Industrial Science, the University of Tokyo, Tokyo 153-8505, Japan.
Akimasa HirataDepartment of Electrical and Mechanical Engineering, Nagoya Institute of Technology, Nagoya 466-8555, Japan.ORCID 0000-0001-8336-1140

Funding

Cabinet Office COVID-19 AI Simulation Project
6 · The paper itself

Abstract

The variability of the COVID-19 vaccination effectiveness (VE) should be assessed with a resolution of a few days, assuming that the VE is influenced by public behavior and social activity. Here, the VE for the Omicron variants (BA.2 and BA.5) is numerically derived for Japan's population for the second and third vaccination doses. We then evaluated the daily VE variation due to social behavior from the daily data reports in Tokyo. The VE for the Omicron variants (BA.1, BA.2, and BA.5) are derived from the data of Japan and Tokyo with a computational approach. In addition, the effect of the different parameters regarding human behavior on VE was assessed using daily data in Tokyo. The individual VE for the Omicron BA.2 in Japan was 61% (95% CI: 57-65%) for the second dose of the vaccination from our computation, whereas that for the third dose was 86% (95% CI: 84-88%). The individual BA.5 VE for the second and third doses are 37% (95% CI: 33-40%) and 63% (95% CI: 61-65%). The reduction in the daily VE from the estimated value was closely correlated to the number of tweets related to social gatherings on Twitter. The number of tweets considered here would be one of the new candidates for VE evaluation and surveillance affecting the viral transmission.

Indexed as

COVID-19Omicron variantTwittervaccination effectiveness

Identifiers

PMID36366329
PMCPMC9694407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.